InsiderClue
Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

Neuraxis, INC

NRXS Clue Score52
United States Fiscal year ends December CIK 0001933567
$6.93 +2.36% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $6.93 +92.50% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 9 Aug 2023. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2022Revenue2.7Operating income−3.4Net income−4.8EPS, diluted−2.77Fiscal year 2023Revenue2.5 −8.4%Operating income−6.7Net income−14.6EPS, diluted−4.50Fiscal year 2024Revenue2.7 +9.2%Operating income−7.2Net income−8.2EPS, diluted−1.22Fiscal year 2025Revenue3.6 +32.9%Operating income−7.8Net income−7.8EPS, diluted−0.95
FY2022FY2023FY2024FY2025
Revenue 2.7 2.5 2.7 3.6
Growth −8.4% +9.2% +32.9%
Operating income −3.4 −6.7 −7.2 −7.8
Net income −4.8 −14.6 −8.2 −7.8
Growth
EPS, diluted −2.77 −4.50 −1.22 −0.95

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2022Gross margin88.9%Operating margin−125.6%Net margin−178.0%Free cash flow margin−85.6%Fiscal year 2023Gross margin87.7%Operating margin−270.9%Net margin−594.6%Free cash flow margin−273.4%Fiscal year 2024Gross margin86.5%Operating margin−266.5%Net margin−306.8%Free cash flow margin−228.1%Fiscal year 2025Gross margin84.2%Operating margin−219.4%Net margin−218.5%Free cash flow margin−181.1%
FY2022FY2023FY2024FY2025
Gross margin 88.9% 87.7% 86.5% 84.2%
Operating margin −125.6% −270.9% −266.5% −219.4%
Net margin −178.0% −594.6% −306.8% −218.5%
Free cash flow margin −85.6% −273.4% −228.1% −181.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2022Operating cash flow−2.3Capital expenditure−0.0Free cash flow−2.3Fiscal year 2023Operating cash flow−6.7Capital expenditure−0.0Free cash flow−6.7Fiscal year 2024Operating cash flow−6.1Capital expenditure−0.0Free cash flow−6.1Fiscal year 2025Operating cash flow−6.4Capital expenditure−0.0Free cash flow−6.5
FY2022FY2023FY2024FY2025
Operating cash flow −2.3 −6.7 −6.1 −6.4
Capital expenditure −0.0 −0.0 −0.0 −0.0
Free cash flow −2.3 −6.7 −6.1 −6.5
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2022Cash0.3Total debt0.2Net cash (debt)0.0Shareholders’ equity−5.6Fiscal year 2023Cash0.1Shareholders’ equity−1.4Fiscal year 2024Cash3.7Shareholders’ equity2.1Fiscal year 2025Cash5.0Shareholders’ equity3.4
FY2022FY2023FY2024FY2025
Cash 0.3 0.1 3.7 5.0
Total debt 0.2 n/a n/a n/a
Net cash (debt) 0.0 n/a n/a n/a
Shareholders’ equity −5.6 −1.4 2.1 3.4

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
88.9% 87.7% 86.5% 84.2%
−125.6% −270.9% −266.5% −219.4%
−178.0% −594.6% −306.8% −218.5%
−85.6% −273.4% −228.1% −181.1%
Spending
8.4% 6.9% 16.1% 13.8%
190.8% 338.5% 282.1% 225.9%
0.1% 1.3% 1.0% 0.9%
Returns
n/a n/a −398.6% −229.5%
−322.8% −2,870.8% −173.2% −121.8%
Balance and payout
476.4% 375.4% 56.5% 46.9%